Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : India Coffee House -- Ignore unavailable to you. Want to Upgrade?

To: Mohan Marette who wrote (3033)	10/14/1998 1:12:00 PM
From: Mohan Marette	Read Replies (1) \| Respond to of 12475

Indian-American claims discovery of vaccine against HIV virus Michel W Potts PLEASANTON (CAL) 12 OCTOBER AN INDIAN-American neurologist has filed an application with the International Patent Office in Geneva to register a recumbent virus vaccine he designed, which he believes will eradicate the HIV virus long before it becomes full-blown AIDS. Known as Contre-Vir and developed by Sateesh Apte, who heads his own ImmunoScience company here, the vaccine is being touted as a "definitive, immune mediated 'cure''' that requires only two injections. economictimes.com